Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 07, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
  7. North America Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  8. Europe Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  9. APAC Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  10. Middle East and Africa Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  11. LATAM Neurodegenerative Disease Market Size Analysis
    1. Introduction
    2. Neurodegenerative Disease Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Multiple Sclerosis
      2. Parkinson's Disease
      3. Alzheimer's Disease
      4. Others
    3. Neurodegenerative Disease Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulator
      2. Vesicular Monoamine Transporter 2 (VMAT2)
      3. Others
    4. Neurodegenerative Disease Market Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous (IV) delivery
      3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Multiple Sclerosis
        2. Parkinson's Disease
        3. Alzheimer's Disease
        4. Others
      3. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulator
        2. Vesicular Monoamine Transporter 2 (VMAT2)
        3. Others
      4. Market Size & Forecast By Routes of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous (IV) delivery
        3. Others
  12. Competitive Landscape
    1. Neurodegenerative Disease Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Amneal Pharmaceuticals Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hoffmann-La Roche
    3. Boehringer Ingelheim International GmbHF
    4. Merck & Co. Inc.
    5. Novartis AG
    6. Pfizer Inc.
    7. Teva Pharmaceuticals Ltd
    8. UCB SA
    9. Biogen Inc
    10. Acadia Pharmaceuticals Inc.
    11. Neuronity Therapeutics, Inc.
    12. Arkuda Therapeutics Inc
    13. NeuroX1 Inc.
    14. Annovis Bio, Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Neurodegenerative Disease Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 3: Global Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 4: Global Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 5: North America Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 7: North America Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 8: North America Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 9: U.S. Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 10: U.S. Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 11: U.S. Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 12: Canada Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 13: Canada Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 14: Canada Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 15: Europe Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 17: Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 18: Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 19: U.K. Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 20: U.K. Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 21: U.K. Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 22: Germany Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 23: Germany Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 24: Germany Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 25: France Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 26: France Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 27: France Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 28: Spain Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 29: Spain Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 30: Spain Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 31: Italy Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 32: Italy Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 33: Italy Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 34: Russia Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 35: Russia Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 36: Russia Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 37: Nordic Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 38: Nordic Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 39: Nordic Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 40: Benelux Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 41: Benelux Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 42: Benelux Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 43: Rest of Europe Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 44: Rest of Europe Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 45: Rest of Europe Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 46: APAC Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 48: APAC Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 49: APAC Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 50: China Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 51: China Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 52: China Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 53: Korea Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 54: Korea Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 55: Korea Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 56: Japan Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 57: Japan Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 58: Japan Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 59: India Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 60: India Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 61: India Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 62: Australia Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 63: Australia Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 64: Australia Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 65: Taiwan Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 66: Taiwan Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 67: Taiwan Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 68: South East Asia Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 69: South East Asia Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 70: South East Asia Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 74: Middle East and Africa Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 76: Middle East and Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 78: UAE Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 79: UAE Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 80: UAE Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 81: Turkey Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 82: Turkey Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 83: Turkey Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 84: Saudi Arabia Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 85: Saudi Arabia Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 86: Saudi Arabia Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 87: South Africa Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 88: South Africa Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 89: South Africa Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 90: Egypt Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 91: Egypt Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 92: Egypt Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 93: Nigeria Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 94: Nigeria Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 95: Nigeria Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 96: Rest of MEA Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 97: Rest of MEA Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 98: Rest of MEA Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 99: LATAM Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 101: LATAM Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 102: LATAM Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 103: Brazil Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 104: Brazil Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 105: Brazil Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 106: Mexico Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 107: Mexico Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 108: Mexico Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 109: Argentina Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 110: Argentina Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 111: Argentina Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 112: Chile Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 113: Chile Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 114: Chile Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 115: Colombia Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 116: Colombia Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 117: Colombia Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 118: Rest of LATAM Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 119: Rest of LATAM Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 120: Rest of LATAM Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

We are featured on: